Hitek Global Inc. - Class A Ordinary Share (HKIT)
0.2840
+0.0611 (27.41%)
NASDAQ· Last Trade: Jun 26th, 6:27 PM EDT
Detailed Quote
| Previous Close | 0.2229 |
|---|---|
| Open | 0.2219 |
| Bid | 0.2869 |
| Ask | 0.2875 |
| Day's Range | 0.2151 - 0.3741 |
| 52 Week Range | 0.2029 - 627.00 |
| Volume | 129,163,736 |
| Market Cap | 3.12M |
| PE Ratio (TTM) | -3.550 |
| EPS (TTM) | -0.1 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 39,996,208 |
Chart
About Hitek Global Inc. - Class A Ordinary Share (HKIT)
Hitek Global Inc is a technology company that focuses on developing and delivering innovative solutions in the fields of data analytics, artificial intelligence, and cybersecurity. The company's offerings cater to a wide range of industries, enabling clients to efficiently harness and analyze large volumes of data to enhance decision-making processes and improve operational efficiency. Additionally, Hitek Global is dedicated to providing robust security measures to protect sensitive information and ensure compliance with regulatory standards, thereby empowering businesses to navigate the complexities of the digital landscape with confidence. Read More
News & Press Releases
Top movers analysis one hour before the close of the markets on 2026-06-26: top gainers and losers in today's session.chartmill.com
Via Chartmill · June 26, 2026
These stocks are making the most noise in today's session.chartmill.com
Via Chartmill · June 26, 2026
Gainers PicoCELA (NASDAQ:PCLA) shares rose 108.8% to $6.41 during Friday's regular session. The company's market cap stands at $29.5 million. Hitek Global (NASDAQ:HKIT) shares moved upwards by 35.75% to $0.3.
Via Benzinga · June 26, 2026
Which stocks are moving on Friday?chartmill.com
Via Chartmill · June 26, 2026
Top movers in Thursday's after hours sessionchartmill.com
Via Chartmill · June 11, 2026
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage biotechnology company focused on Alzheimer’s disease, artificial intelligence , and drug discovery , is drawing renewed investor attention after Ascendiant Capital reiterated its BUY rating and increased its 12-month price target to $5.50 , citing multiple potential catalysts expected throughout 2026.
Via AB Newswire · June 11, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · June 11, 2026
Wondering what's happening in today's pre-market session?chartmill.com
Via Chartmill · June 11, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · June 10, 2026
Check out the stocks that are attracting the most attention and driving market activity.chartmill.com
Via Chartmill · June 10, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · June 10, 2026
Wednesday's session: gap up and gap down stockschartmill.com
Via Chartmill · June 10, 2026
Wednesday's pre-market session: top gainers and loserschartmill.com
Via Chartmill · June 10, 2026
Thursday's after hours session: top gainers and loserschartmill.com
Via Chartmill · June 4, 2026
These stocks that are showing activity before the opening bell on Thursday.chartmill.com
Via Chartmill · June 4, 2026
Which stocks are moving on Wednesday?chartmill.com
Via Chartmill · June 3, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · June 3, 2026
Which stocks are gapping on Wednesday?chartmill.com
Via Chartmill · June 3, 2026
These stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · June 3, 2026
Tuesday's session: gap up and gap down stockschartmill.com
Via Chartmill · June 2, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · June 2, 2026
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage AI biotechnology company focused on Alzheimer’s disease, is gaining investor attention after CEO Ram Mukunda appeared on Bloomberg TV discussing the company’s lead drug candidate, IGC-AD1, a potential fast-acting therapy for agitation associated with Alzheimer’s dementia .
Via AB Newswire · June 1, 2026